This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Hitting Highs Even Amid Turmoil

BOSTON ( TheStreet) -- Even in a down market, there are winners: Companies that are growing despite macro-economic turbulence. Here's a look at five stocks that hit 52-week highs yesterday as the S&P 500 Index fell 2%, erasing its gain in 2011. They are fast-growth companies that have little correlation with the economic and political woes weighing on other equities. Below is a look at the stocks' performance, fundamentals and outlook.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

5. Examworks Group (EXAM - Get Report) is a specialty company providing independent medical examinations, used by insurance companies and employers to determine the impact and legitimacy of a patient's claims. Examworks is based in Atlanta, but also has offices in New York and 27 other locations in the U.S., Canada and the U.K. The company went public in late October with lead book-runners Goldman Sachs, Barclays and Credit Suisse. Its stock has advanced 45% since the initial sale, outperforming U.S. indices. Its shares have already appreciated 31% during 2011.

Examworks' fourth-quarter revenue more than tripled to $54 million. Its sales exceeded analysts' consensus expectations by 2.3%. The vast majority of the revenue increase resulted from inorganic growth. Examworks has purchased U.K. Independent Medical Service, BME Gateway, Royal Medical Consultants and, most recently, MES Group since it went public. The company swung to an adjusted loss of 3 cents a share and a GAAP loss of 20 cents in the latest quarter, but EBITDA multiplied to $10 million. It expects $350 million to $360 million of sales during fiscal 2011.
1 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
EXAM $39.42 0.82%
JAZZ $177.13 0.60%
PLCM $11.42 -0.17%
SIX $45.42 1.27%
ULTA $155.42 0.63%

Markets

DOW 17,780.72 +22.81 0.13%
S&P 500 2,077.42 +14.31 0.69%
NASDAQ 5,013.1230 +26.2560 0.53%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs